Consistent with previous studies, we found that YTHDF1 was highly expressed in prostate cancer cells and reduced expression of YTHDF1 inhibited PCa cell proliferation, migration, and invasion, suggesting that YTHDF1 may represent a target for PCa treatment. Here, YTHDF1 is linked to prostate cancer.